Why did UBS set a 750p target for Aviva?

UBS points to a well-protected balance sheet and capital-light growth that supports cash returns. It prefers Aviva over Legal & General ahead of 5 March results. The broker believes these strengths can back dividends and optionality, which could justify a re-rating toward 750p if execution stays consistent.

When are Aviva’s next results and why do they matter?

Aviva reports on 5 March. Investors want clarity on solvency movement, operating cash, and dividend plans. Strong capital build and a dependable payout framework could support sentiment. Any detail on capital allocation, sensitivities, and priorities for buybacks or debt can also influence the valuation in the near term.

How does the dividend fit into the investment case?

Dividends are central to Aviva’s pitch for UK income investors. The focus is on sustainable cash coverage and a clear policy. Guidance that confirms a progressive path and explains trade-offs between growth, debt, and distributions would be supportive for the shares and could help narrow any valuation gap.

What could trigger buybacks from 2026?

Buybacks depend on surplus capital after funding organic growth, dividends, and balance sheet needs. If management demonstrates consistent capital build and comfortable coverage, excess distributions may return from 2026. Clear milestones at results and through 2025 would help investors judge the timing and scale of any potential programme.

Global Market Insights

AV.L Stock Today: January 28 UBS Backs Aviva; 750p PT, 19% Upside

ByHuzaifa Zahoor January 28, 2026January 28, 2026

Aviva share price UBS is in focus today after UBS named Aviva its preferred UK life insurer and set a 750p price target, implying about 19% upside. Aviva (AV.L) heads into 5 March results with attention on solvency build, cash generation, and the dividend path. UBS highlights a well-protected balance sheet and capital-light growth. We explain why the broker favours Aviva over Legal & General, how 750p stacks up, and which catalysts could move the shares for UK investors in the weeks ahead.